Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Here's Why AstraZeneca Dipped 14.2% in October
Here's Why AstraZeneca Dipped 14.2% in October
Here's Why AstraZeneca Dipped 14.2% in October
Submitted by
admin
on November 10, 2016 - 10:22am
Source:
Motley Fool
News Tags:
AstraZeneca
AZD9412
durvalumab
Brilinta
Headline:
Here's Why AstraZeneca Dipped 14.2% in October
Do Not Allow Advertisers to Use My Personal information
